| Literature DB >> 32844169 |
Guizi Ye1,2, Hongyu Wu1,3, Jinjiang Huang2,3, Wei Wang3, Kuikui Ge1, Guodong Li3, Jiang Zhong1, Qingshan Huang1.
Abstract
Antimicrobial peptides (AMPs) have been regarded as a potential weapon to fight against drug-resistant bacteria, which is threating the globe. Thus, more and more AMPs had been designed or identified. There is a need to integrate them into a platform for researchers to facilitate investigation and analyze existing AMPs. The AMP database has become an important tool for the discovery and transformation of AMPs as agents. A database linking antimicrobial peptides (LAMPs), launched in 2013, serves as a comprehensive tool to supply exhaustive information of AMP on a single platform. LAMP2, an updated version of LAMP, holds 23 253 unique AMP sequences and expands to link 16 public AMP databases. In the current version, there are more than 50% (12 236) sequences only linking a single database and more than 45% of AMPs linking two or more database links. Additionally, updated categories based on primary structure, collection, composition, source and function have been integrated into LAMP2. Peptides in LAMP2 have been integrated in 8 major functional classes and 38 functional activities. More than 89% (20 909) of the peptides are experimentally validated peptides. A total of 1924 references were extracted and regarded as the evidence for supporting AMP activity and cytotoxicity. The updated version will be helpful to the scientific community.Entities:
Keywords: LAMP; antimicrobial peptides; database
Mesh:
Substances:
Year: 2020 PMID: 32844169 PMCID: PMC7447557 DOI: 10.1093/database/baaa061
Source DB: PubMed Journal: Database (Oxford) ISSN: 1758-0463 Impact factor: 3.451
Figure 1A total of 23 253 entries are distributed in 16 different databases in LAMP2.
Comparison of data in two versions of LAMP database
| Group | LAMP | LAMP2 | |
|---|---|---|---|
| By primary structure | Linear | / | 22 934 |
| Cyclic | 319 | ||
| By collection | Experimental validated peptides | 3203 | 20 909 |
| Patent peptides | 1491 | 1491 | |
| Predicted peptides | 853 | 853 | |
| By composition | Peptides having D-amino acids | / | 839 |
| Peptides having natural amino acids | 21 691 | ||
| Peptides having modified residues | 723 | ||
| By source | Synthetic peptides | 1643 | 15 429 |
| Natural peptides | 3904 | 7824 | |
New categories based on functional activity in LAMP2
| Function classes | Functional activity | Numbers of AMPs |
|---|---|---|
| Antibacterial | Antibacterial | 15 844 |
| Anti-Gram positive | 7026 | |
| Anti-Gram negative | 7101 | |
| Antifungal | Antifungal | 2147 |
| Antiviral | Antiviral | 4241 |
| Antiparasitic | Antiparasitic | 374 |
| New functional peptides | Wound healing | 19 |
| Antioxidant | 22 | |
| Spermicidal | 13 | |
| Enzyme inhibitor | 25 | |
| Mollicute | 16 | |
| Antihypertensive | 15 | |
| Disease-associated peptides | Anti-MRSA | 114 |
| Anti-HIV | 105 | |
| Anti-inflammatory | 2 | |
| Anticancer | 1314 | |
| Anti-tumor | 22 | |
| New mechanism-associated peptides | Chemotactic | 50 |
| Sodium channel blocker | 2 | |
| Surface immobilized | 10 | |
| Anti-biofilm | 34 | |
| Cancer cells | 223 | |
| Mammalian cells | 3682 | |
| Blood-brain barrier | 10 | |
| Cell penetrating | 12 | |
| Tumor homing | 2 | |
| Hormones | 3 | |
| Quorum sensing | 5 | |
| Toxic | Hemolytic | 1601 |
| Cytotoxic | 244 |
Figure 2Cross-links to other databases in LAMP2.
Figure 3Venn diagram demonstrating peptides cross links among the top 5 databases in LAMP2 (plotted using http://bioinformatics.psb.ugent.be/webtools/Venn/).
Figure 4Top 5 AMPs in the number of cross-links in LAMP2.